mains of CBP/p300 (Nakashima et al., 1999), and the
. neural stem cells (Nakashima et al., 1999 neurogenesis at the expense of gliogenesis. During cortical development, neurogenesis precedes glial differentiwas generated to introduce exogenous Ngn1 into dividing cortical precursor cells cultured from rat E14 cortiation. One possibility is that glial-inducing cues are only expressed after neuronal differentiation is complete. Alces. For this analysis, we also used a control virus that expresses a mutant Ngn1 gene, Ngn1(nm), with two stop ternatively, Ngn1 might actively inhibit gliogenesis even in the presence of glial-inducing cues, ensuring that the codons inserted after the initiator methionine codon, so that no Ngn1 protein is produced. When cortical precurprocess of neurogenesis is completed before gliogenesis can begin. sor cells were infected with the Ngn1 or Ngn1(nm)/control viruses, we found that exogenous Ngn1 expression To explore whether Ngn1 can still induce neurogenesis in the presence of glial-inducing factors, we examined the led to a significant increase in the number of precursors that become neurons, as compared with the control. effect of Ngn1 on neuronal and glial differentiation in cells treated with LIF/CNTF. Ectopically expressed Ngn1, but Neurons were identified by cell morphology, and by the expression of neuronal-specific markers such as the not Ngn1(nm)/control, was able to inhibit cytokineinduced astrocyte differentiation in both cortical precur-␤-tubulin/TuJ1 antigen ( Figures 1A and 1B) and the microtubule-associated protein MAP2 (data not shown).
sor and neural stem cell cultures. Astrocytes were identified by their morphology and by the expression of GFAP. In addition, the expression of Ngn1 led to downregulation of the expression of the neuroepithelial precursor In E14 cortical cultures treated for four days with CNTF, neurogenin expression reduced the number of GFAPmarker Nestin. This finding suggests that ectopic Ngn1 effectively induces the process of neuronal differentiaexpressing astrocytes by 80% ( Figures 1C and 1D ). In addition, Ngn1-expressing cells display a neuronal-like tion, rather than simply inducing the expression of selected neuronal-specific markers in progenitor cells. morphology (small round cell bodies with one or two simple processes) that is quite distinct from the stellate The induction of neurogenesis by Ngn1 could be due to enhanced neuronal survival or increased proliferation of GFAP-positive astrocytes. This implies that Ngn1 is not only regulating GFAP expression but may also affect committed neuroblasts rather than neuronal differentiation per se. However, the exogenous Ngn1-expressing cells other aspects of astrocyte differentiation. The change in morphology is also seen when Ngn1 do not show increased cell survival or proliferation rates as compared with nonexpressing cells, ruling out either is expressed in neural stem cells in the presence of CNTF, which would normally cause the differentiation of these alternative explanations (data not shown).
The possibility that Ngn1 instructively promotes neuof virtually all of the stem cells into astrocytes (Figure genes at the transcriptional level. Coexpression of Ngn1 of these two regions contains E box-like sequences, so we searched for other known DNA binding elements. significantly suppressed GFAP promoter activity, even when the cells were stimulated with glial-inducing facUsing Transcription Element Search Software, we identified a putative c-Ets1 site at Ϫ1685 bp, an AP1 site at tors such as CNTF/LIF or BMP ( Figure 3A ). Ngn1 similarly suppressed the GFAP promoter-luciferase reporter ac-Ϫ1525 bp, a STAT binding site at Ϫ1435 bp, as well as cryptic myogenin binding sites. A more detailed mutativity in neural stem cell cultures (data not shown). These data suggest that Ngn1, either directly or indirectly, retional analysis, involving deletions and substitutions of single and multiple sites, was undertaken. The results presses the transcription of glial-specific genes.
Neurogenin might inhibit astrocyte gene expression obtained suggest that, although the myogenin sites are not involved, a number of the other identified sites as in one of three ways. There might be E box sequences in astrocyte-specific promoters, and neurogenin might well as several novel sites, are important for the repression of the GFAP promoter by Ngn1. Of these sites, act as or recruit a transcriptional repressor to these sites. Alternatively, Ngn1 might function as a transcripmutation of the STAT binding element, previously known to be important for LIF/CNTF-and BMP-induced exprestional activator (as it has classically been described), upregulating a glial repressor. Lastly, neurogenin might sion of this gene (Bonni et al., 1997; Nakashima et al., 1999), was most effective in reversing Ngn1 repression inhibit astrocyte differentiation independent of its ability to bind to DNA, for example, via a protein-protein interof the GFAP promoter activity ( Figure 3B) . Though it appears that the STAT binding site is reaction that sequesters an activator(s) of glial-specific gene expression. The results described below led us to quired for neurogenin to exert its full repressive effect on the GFAP promoter, we found that Ngn1 does not favor the third of these possibilities.
We performed a detailed deletion and substitution bind directly to the STAT binding element (data not shown). Furthermore, the fact that multiple DNA regulamutation analysis of the GFAP promoter to identify DNA cis-acting elements that participate in the transcriptional tory elements contribute to Ngn1 repression of the GFAP promoter suggests that Ngn1 might inhibit glial gene repression by Ngn1. This analysis indicated that two regions of the GFAP promoter, Ϫ1876 bp to Ϫ1546 bp activation by interfering with a transcription cofactor that mediates the effects of multiple promoter bound and Ϫ1546 bp to Ϫ1342 bp, are involved in the repression of the GFAP promoter by Ngn1 ( Figure 3B) . Neither transcription factors. Ngn1 mutants were introduced into neural stem cells, the Ngn1 mutants failed to induce neurogenesis (data To examine whether E box binding is required for Ngn1 to inhibit glial differentiation, we generated two not shown). However, given that there is a putative nu-clear localization sequence (NLS) contained within neutween CBP-Smad1 and Ngn1 is a consequence of overexpression, we asked whether this association occurs rogenin's basic region, it remained a possibility that these mutants were transcriptionally inactive because in the developing cortex. We hypothesized that early in the development of the cortex, when neurogenin expresthey could not enter the nucleus, not because the mutants were unable to bind to the E box. We examined the sion is at its peak, the neurogenins bind CBP and Smad1, thus inhibiting the ability of CBP-Smad1 to interact with subcellular localization of the exogenous Myc-tagged wild-type and various mutant neurogenins in mammaSTATs and to activate glial differentiation during the time of neurogenesis. To test this idea, we examined lian 293T cells, embryonic neural stem cells, and cortical progenitor cells. We found that wild-type Ngn1 predomithe association of CBP-Smad1, Ngn1, and STATs in extracts from rat E14 cerebral cortex. In these extracts, nantly localized to the nucleus. The subcellular localization of AQ-Ngn1 was indistinguishable from that of CBP was found to associate with both Ngn1 and Smad1 ( Figure 5E ), but not with STAT3 even though STAT3 is the wild-type Ngn1, whereas D-Ngn1 was distributed equally throughout the cell, as was also seen with the expressed at high levels in these extracts ( Figure 5F ). In contrast, we found that STAT3 did associate with Ngn1(nm) mutant control ( Figure 4C) .
Both of the basic domain mutants were tested for their CBP in protein extracts of postnatal day 3 (P3) cortical subventricular zone (SVZ) where the glial-producing preability to inhibit astrocyte differentiation. We found that AQ-Ngn1, though unable to bind to the E box or induce cursor cells reside and at a time when neurogenin is no longer expressed ( Figure 5F ). neurogenesis, still effectively suppresses astrocyte differentiation ( Figure 4D 
, 1999). STATs and Smads do not apcells rapidly give rise to astrocytes. This is in contrast
to what is seen with younger cortical progenitors (E13/ pear to interact directly, but do so via CBP/p300. We hypothesized that Ngn1 might interfere with the recruit-14), where LIF/CNTF stimulation leads to LIF receptor activation but nonetheless leads to poor STAT activation ment of CBP/p300 to the promoter of astrocyte-specific genes by interfering with its ability to bind STAT proteins. and no direct GFAP induction (M. N. V. and M. E. G., unpublished observations). Given that neurogenins are In progenitor or stem cell cultures that are actively giving rise to astrocytes, endogenous CBP was found to interexpressed at low levels in E17/18 cortical progenitors and at high levels in E13/14 progenitors, we considered act with endogenous STAT3 (Figure 5A ). However, this interaction is inhibited by ectopic expression of Ngn1 the possibility that Ngn1 expressed in E13/14 progenitors might be inhibiting LIF-induced STAT phosphorylain these cells ( Figure 5A ). The ability of Ngn1 to inhibit the association between STATs and CBP is independent tion in these cultures. We measured the level of STAT activation using phosof its ability to bind DNA ( Figure 5B) , and might result from the fact that Ngn1 itself is capable of binding to pho-specific antibodies. In neural stem cells, LIF/CNTF stimulation triggers the phosphorylation of STAT1 and both CBP and Smad1 (Figures 5C and 5D) .
To exclude the possibility that the association be-STAT3 at tyrosines 701 and 705, respectively. These
Discussion
We have shown that neurogenin1, a bHLH transcription factor, can actively inhibit gliogenesis in a manner that is independent of its ability to induce neuronal differentiation. Ngn1 inhibits various aspects of astrocyte differentiation, such as the acquisition of an astrocytic morphology and the expression of cell type-specific markers such as GFAP and s100␤, and it can do so without inducing neurogenesis. We have uncovered a novel mechanism of neurogenin action that does not rely on neurogenin's astrocyte differentiation since our analysis of the GFAP promoter identified multiple sites, including an AP-1 site, Our findings suggest that during early cortical development, endogenous Ngn1 associates with both CBP that contribute to neurogenin's inhibition of the GFAP promoter. Taken together, our findings and those of and Smad1, and that the presence of neurogenin blocks STAT binding to CBP. During the course of our study, others suggest that CBP/p300 may orchestrate broad programs of gene expression that are relevant to cell it was reported that Xenopus neurogenin recruits CBP/ p300 to the NeuroD promoter to activate transcription fate determination. The effect of CBP/p300 on cell fate may then be determined by the relative binding affinity and induce neurogenesis. The characterization of the and abundance of different transcription factors that the astrocytic features of the GFAP-positive cells so that these cells can give rise to neurons. However, in the either compete or cooperate with one another for binding to CBP/p300. adult brain, outside of the hippocampus and the subventricular zone (which gives rise to the olfactory rostral migratory stream), neural stem cells rarely give rise to Neurogenin Inhibits STAT Phosphorylation neurons, possibly because these cells express very low In addition to sequestering the CBP-Smad1 complex, neulevels of neurogenic bHLH factors. We propose that the rogenin also inhibits the activation of astrocyte-specific manipulation of neurogenic bHLH factors within neural genes by blocking STAT activation. The mechanism by stem cells may provide a means of enhancing the ability which Ngn1 reduces the level of phospho-STAT1 and of stem cells to generate large numbers of neurons that -STAT3 is unknown. We have preliminary data suggesting might be useful for treating neurodegenerative disorders that the AQ-Ngn1 can also inhibit STAT phosphorylation, or repairing the injured nervous system. though not to the extent seen with wild-type Ngn1. This suggests that Ngn1 inhibits STAT phosphorylation only in part by a mechanism that is independent of Ngn1 
